Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas

American Journal of Pathology

Volumn 151, Issue 5, 1997, Pages 1447-1454

  Fujii, Hiroaki ^a,b   Inagaki, Mitsuhiro ^c   Kasai, Shinichi ^c   Miyokawa, Naoyuki ^c   Tokusashi, Yoshihiko ^c   Gabrielson, Edward ^a   Hruban, Ralph H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JUNTENDO UNIVERSITY   (Japan)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CELL LOSS; CHROMOSOME 1P; CLINICAL ARTICLE; CLONAL ANERGY; FEMALE; GENETIC HETEROGENEITY; HISTOLOGY; HUMAN; MALE; MUCINOUS CARCINOMA; PANCREAS CANCER; PANCREAS DUCT; PAPILLARY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADENOCARCINOMA, MUCINOUS; AGED; ALLELES; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHROMOSOME MAPPING; DISEASE PROGRESSION; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; VARIATION (GENETICS);

EID: 0030665130     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Loftus EV, Olivares-Pakzad BA, Batts KP, Adkins MC, Stephens DH, Sarr MG, DiMagno EP: Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome and nomenclature. Gastroenterology 1996, 110:1909-1918
2. Obara T, Maguchi H, Saitoh Y, Sohma M, Tsuji K, Koike Y, Takemura K, Ura H, Namiki M: Intraductal papillary neoplasms of the pancreas: diagnosis by endoscopic pancreatic biopsy. Endoscopy 1993, 25: 290-293
3. Santini D, Campione O, Salerno A, Gullo L, Mazzoleni G, Leone O, Martinelli G, Marrano D: Intraductal papillary-mucinous neoplasm of the pancreas: a clinicopathologic entity. Arch Pathol Lab Med 1995, 119:209-213
4. Shyr Y, Su CH, Tsay SH, Lui WY: Mucin producing neoplasms of the pancreas: intraductal papillary and mucinous cystic neoplasms. Ann Surg 1996, 223:141-146
5. Tenner S, Carr-Locke DL, Banks PA, Brooks DC, Van Dam J, Farraye FA, Turner JR, Lichtenstein DR: Intraductal mucin-hypersecreting neoplasm "Mucinous ductal ectasia": endoscopic recognition and management. Am J Gastroenterol 1996, 91:2548-2554
6. Yamaguchi K, Ogawa Y, Chijiiwa K, Tanaka M: Mucin hypersecreting tumors of the pancreas: assessing the grade of malignancy preoperatively. Am J Surg 1996, 171:427-431
7. Itai Y, Ohhashi K, Nagai H, Murakami Y, Kokubo T, Makita K, Ohtomo K: Ductectatic mucinous cystadenoma and cystadenocarcinoma of the pancreas. Radiology 1986, 161:697-700
8. Kawarada Y, Yano T, Yamamoto T, Yokoi H, Imai T, Ogura Y, Mizumoto R: Intraductal mucin-producing tumors of the pancreas. Am J Gastroenterol 1992, 87:634-638
9. Ohta T, Nagakawa T, Akiyama T, Fukushima W, Ueno K, Miyazaki I, Suzuki M, Matsui O, Terada T, Nakanuma Y, Kanno M, Uogishi M, Sodani H: The "duct-ectatic" variant of mucinous cystic neoplasm of the pancreas: clinical and radiologie studies of seven cases. Am J Gastroenterol 1992, 87:300-304
10. Rickaert F, Cremer M, Deviere J, Tavares L, Lambilliotte JP, Schröder S, Wurbs D, Klöppel G: Intraductal mucin-hypersecreting neoplasms of the pancreas. Gastroenterology 1991, 101:512-519
11. Ohhashi K, Murakami Y, Takekoshi T: Four cases of "mucin producing" cancer of the pancreas on specific findings of the papilla of Vater. Prog Dig Endosc 1982, 20:348-351
12. Block KP, Mahvi D, Voytovich M, Watkins JL, Mosley R, Reichelderfer M: Mucinous ductal ectasia in an octogenarian: successful treatment with the Whipple procedure. Am J Gastroenterol 1996, 91:388-390
13. Longnecker DS: Intraductal papillary-mucinous tumors of the pancreas. Arch Pathol Lab Med 1995, 119:197-198
14. Barthet M, Spinosa S, Bernard JP, Payan MJ, Berthier J, Sahel J: An association between villous adenomas and mucinous ductal ectasia of the pancreas. Endoscopy 1995, 27:601-603
15. Adsay V, Conlon K, Brennan M, Klimstra D: Intraductal papillary-mucinous neoplasms of the pancreas (IPMN): an analysis of in situ and invasive carcinomas associated with 23 cases. Mod Pathol 1997, 10:143A
16. Tian F, Myles J, Howard JM: Mucinous pancreatic ductal ectasia of latent malignancy: an emerging clinicopathologic entity. Surgery 1992, 111:109-113
17. DiGiuseppe JA, Yeo CJ, Hruban RH: Molecular biology and the diagnosis and treatment of adenocarcinoma of the pancreas. Adv Anat Pathol 1996, 3:139-155
18. Schutte M, Hruban RH, Hedrick L, Cho KR, Nadasdy GM, Weinstein CL, Bova GS, Isaacs WB, Cairns P, Nawroz H, Sidransky D, Casero RA, Meltzer PS, Hahn SA, Kern SE: DPC4 gene in various tumor types. Cancer Res 1996, 56:2527-2530
19. Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996, 271:350-353
20. Hahn SA, Hoque ATMS, Moskaluk CA, da Costa LT, Schutte M, Rozenblum E, Seymour AB, Weinstein CL, Yeo CJ, Hruban RH, Kern SE: Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res 1996, 56:490-494
21. Bartsch D, Shevlin DW, Tung WS, Kisker O, Wells SA, Goodfellow PJ: Frequent mutations of CDKN2 in primary pancreatic adenocarcinomas. Genes Chromosomes & Cancer 1995, 14:189-195
22. Huang L, Goodrow TL, Zhang SY, Klein-Szanto A, Chang H, Ruggeri B: Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas. Cancer Res 1996, 56:1137-1141
23. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE: Frequent somatic mutations and homozygous deletions of the p16 (MTSI) gene in pancreatic adenocarcinoma. Nature Genet 1994, 8:27-32
24. Naumann M, Savitskaia N, Eilert C, Schramm A, Kalthoff H, Schmiegel W: Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors. Gastroenterology 1996, 110:1215-1224
25. Rozenblum E, Schutte M, Goggins M, Hahn SA, Panzer S, Zahurak M, Goodman SN, Sohn TA, Hruban RH, Yeo CJ, Kern SE: Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res 1997, 57: 1731-1734
26. Weyrer K, Feichtinger H, Haun M, Weiss G, Ofner D, Weger AR, Umlauft F, Grunewald K: p53, ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas. Lab Invest 1996, 74:279-289
27. Scarpa A, Capelli P, Mukai K, Zamboni G, Oda T, Iacono C, Hirohashi S: Pancreatic adenocarcinomas frequently show p53 gene mutations. Am J Pathol 1993, 142:1534-1543
28. Redston MS, Caldas C, Seymour AB, Hruban RH, da Costa L, Yeo CJ, Kern SE: p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res 1994, 54:3025-3033
29. Hahn SA, Seymour AB, Hoque ATMS, Schutte M, da Costa L, Redston MS, Caldas C, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE: Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res 1995, 55:4670-4675
30. Seymour AB, Hruban RH, Redston M, Caldas C, Powell SM, Kinzler KW, Yeo CJ, Kern SE: Allelotype of pancreatic adenocarcinoma. Cancer Res 1994, 54:2761-2764
31. Klöppel G, Solcia E, Longnecker DS, Capella C, Sobin LH: World Health Organization International Histological Classification of Tumours, ed 2. Berlin, Springer-Verlag, 1996
32. Fujii H, Szumel R, Marsh C, Zhou W, Gabrielson E: Genetic progression, histological grade and allelic loss in ductal carcinoma in situ of the breast. Cancer Res 1996, 56:5260-5265
33. Japanese Pancreas Society: Classification of Pancreatic Carcinoma (1st English edition). Tokyo, Kanehara and Co., Tokyo, 1996
34. Hoshi T, Imai M, Ogawa K: Frequent K-ras mutations and absence of p53 mutations in mucin-producing tumors of the pancreas. J Surg Oncol 1994, 55:84-91
35. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767
36. Boland CR, Sato J, Appelman HD, Bresalier RS, Feinberg AP: Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression. Nature Med 1995, 1:902-909
37. Fujii H, Marsh C, Cairns P, Sidransky D, Gabrielson E: Genetic divergence in the clonal evolution of breast cancer. Cancer Res 1996, 56:1493-1497
38. Sessa F, Solcia E, Capella C, Bonato M, Scarpa A, Zamboni G, Pellegata NS, Ranzani GN, Rickaert F, Klöppel G: Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch 1994, 425:357-367
39. Zgraggen K, Rivera J, Pins M, Lewandrowski KB, Werner J, Rattner DW, Dernandez-del Castil C, Compton CC, Rustigi AK, Warshaw AL: Prevalence of K-ras mutations in the stages of evolution of neoplasia in intraductal papillary mucinous tumors of the pancreas. Ann Surg 1997 (in press)
40. Yanagisawa A, Ohtake K, Ohhashi K, Hori M, Kitagawa T, Sugano H, Kato Y: Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 1993, 53:953-956
41. Cerny WL, Mangold KA, Scarpelli DG: K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster. Cancer Res 1992, 52:4507-4513
42. Hruban RH, DiGiuseppe JA: K-ras mutations in pancreatic ductal proliferative lesions: author's reply. Am J Pathol 1994, 145:1548-1550
43. Hameed M, Marrero AM, Conlon KC, Brennan MF, Klimstra DS: Expression of p53 nucleophosphoprotein in in situ pancreatic ductal adenocarcinoma: an immunohistochemical analysis of 100 cases. Lab Invest 1994, 70:132A
44. Pour PM, Sayed S, Sayed G: Hyperplastic, preneoplastic, and neoplastic lesions found in 83 human pancreases. Am J Clin Pathol 1982, 77:137-152
45. Kozuka S, Sassa R, Taki T, Masamoto K, Nagasawa S, Saga S, Hasegawa K, Takeuchi M: Relation of pancreatic duct hyperplasia to carcinoma. Cancer 1979, 43:1418-1428
46. Cubilla AL, Fitzgerald PJ: Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res 1976, 36:2690-2698
47. Furukawa T, Chiba R, Kobari M, Matsuno S, Nagura H, Takahashi T: Varying grades of epithelial atypia in the pancreatic ducts of humans: classification based on morphometry and multivariate analysis and correlated with positive reactions of carcinoembryonic antigen. Arch Pathol Lab Med 1994, 118:227-234
48. Brat DJ, Warfield PB, Hruban RH: Progression of pancreatic intraductal lesions (high grade PanlN) to infiltrating adenocarcinoma of the pancreas. Mod Pathol 1997, 10:53A
49. Boschman C, Stryker S, Reddy JK, Rao MS: Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas. Am J Pathol 1994, 145:1291-1295
50. DiGiuseppe JA, Hruban RH, Goodman SN, Polak M, van den Berg FM, Allison DC, Cameron JL, Offerhaus GJA: Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol 1994, 101:684-688
51. Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, Kern SE: Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res 1994, 54:3568-3573
52. Moskaluk CA, Hruban RH, Kern SE: p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 1997, 57:2140-2143
53. Tada M, Ohashi M, Shiratori Y, Okudaira T, Komatsu Y, Kawabe T, Yoshida H, Machinami R, Kishi K, Omata M: Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology 1996, 110:227-231
54. Gorunova L, Johansson B, Dawiskiba S, Andren-Sandberg A, Jin Y, Mandahl N, Heim S, Mitelman F: Massive cytogenetic heterogeneity in a pancreatic carcinoma: fifty-four karyotypically unrelated clones. Genes Chromosomes & Cancer 1995, 14:259-266
55. Bardi G, Sukhikh T, Pandis N, Fenger C, Kronborg O, Heim S: Karyotypic characterization of colorectal adenocarcinomas. Genes Chromosomes & Cancer 1995, 12:97-109
56. Heim S, Mandahl N, Mitelman F: Genetic convergence and divergence in tumor progression. Cancer Res 1988, 48:5911-5916
57. Jin Y, Mertens F, Mandahl N, Heim S, Olegard C, Wennerberg J, Biorklund A, Mitelman F: Chromosome abnormalities in eighty three head and neck squamous cell carcinomas: influence of culture conditions on karyotypic pattern. Cancer Res 1993, 53:2140-2146
58. Heim S, Jin Y, Mandahl N, Biörklund A, Wennerberg J, Jonsson N, Mitelman F: Multiple unrelated clonal chromosome abnormalities in an in situ squamous cell carcinoma of the skin. Cancer Genet Cytogenet 1988, 36:149-153
59. Gorunova L, Johansson B, Dawiskiba S, Andrén-Sandberg A, Mandahl N, Heim S, Mitelman F: Cytogenetically detected clonal heterogeneity in a duodenal adenocarcinoma. Cancer Genet Cytogenet 1995, 82:146-150
60. Lengauer C, Kinzler KW, Vogelstein B: DNA methylation and genetic instability in colorectal cancer cells. Proc Natl Acad Sci USA 1997: 94:2545-2550
61. Lengauer C, Kinzler KW, Vogelstein B: Genetic instability in colorectal cancers. Nature 1997, 386:623-627
62. Hruban RH, van Mansfeld ADM, Offerhaus GJA, van Weering DHJ, Allison DC, Goodman SN, Kensler TW, Bose KK, Cameron JL, Bos JL: K-ras oncogene activation in adenocarcinoma of the human pancreas: a study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993, 143:545-554
63. DiGiuseppe JA, Redston MS, Yeo CJ, Kern SE, Hruban RH: p53-independent expression of the cyclin dependent kinase inhibitor p21 in pancreatic carcinoma. Am J Pathol 1995, 147:884-888
64. Tada M, Omata M, Ohto M: Ras gene mutations in intraductal papillary neoplasms of the pancreas. Cancer 1991, 67:634-637